Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...

a product for a rare disease that has a steroid reduction component as part of its Phase 3 clinical trial and FDA approval package. We anticipate his contributions will be highly valuable as we ...

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

There are many outputs produced during a clinical trial, and one of the most crucial is the Clinical Study Report (CSR). It details the results, methodology, and analysis of the trial, providing ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, March 16, 2025, the moon is 15 days old and is in the Waning Gibbous phase of its lunar ...

The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...

Results from the phase 1 clinical trial, published in the journal Nature, revealed that the vaccine triggered an immune response in a small patient group. This immune-cell activation persisted for ...

today announced its decision to discontinue the Phase 1 single- and multiple-ascending dose (SAD/MAD) clinical trial of SEP-786 in healthy volunteers. SEP-786 is an oral small molecule agonist of ...